Filing Details

Accession Number:
0000313143-13-000069
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-05-02 19:18:07
Reporting Period:
2013-04-30
Filing Date:
2013-05-02
Accepted Time:
2013-05-02 19:18:07
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
313143 Haemonetics Corp HAE Surgical & Medical Instruments & Apparatus (3841) 042882273
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1261832 M Peter Allen 400 Wood Road
Braintree MA 02184
President, Global Plasma No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-04-30 451 $32.73 26,797 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Non-Qualified Stock Option (right to buy) $13.05 2005-05-05 2014-05-05 30,000 30,000 Direct
Common Stock Non-Qualified Stock Option (right to buy) $25.54 2008-10-24 2014-10-24 36,426 36,426 Direct
Common Stock Non-Qualified Stock Option (right to buy) $26.47 2010-10-27 2016-10-27 31,340 31,340 Direct
Common Stock Non-Qualified Stock Option (right to buy) $27.28 2009-10-22 2015-10-22 30,494 30,494 Direct
Common Stock Non-Qualified Stock Option (right to buy) $27.50 2011-10-27 2017-10-27 30,776 30,776 Direct
Common Stock Non-Qualified Stock Option (right to buy) $30.67 2012-10-25 2018-10-25 30,740 30,740 Direct
Common Stock Non-Qualified Stock Option (right to buy) $39.06 2013-10-24 2019-10-24 32,192 32,192 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2014-05-05 30,000 30,000 Direct
2014-10-24 36,426 36,426 Direct
2016-10-27 31,340 31,340 Direct
2015-10-22 30,494 30,494 Direct
2017-10-27 30,776 30,776 Direct
2018-10-25 30,740 30,740 Direct
2019-10-24 32,192 32,192 Direct
Footnotes
  1. Acquisition of shares of Common Stock pursuant to the Employee Stock Purchase Plan. Participant elected to purchase shares at least six months in advance of the effective date of the transaction.
  2. Total includes Restricted Stock Awards and/or Restricted Stock Units that are subject to restrictions until vesting requirements are met. Grant was made under 2005 Long Term Incentive Compensation Plan.
  3. Grant to reporting person of right to buy shares of common stock exercisable in annual increments of 25 percent beginning on the first anniversary of the date of grant.